Table 4.
| Design | T/t group | Baseline | 1 week | % reduction | 2 weeks | % reduction |
|---|---|---|---|---|---|---|
| Lycopene | OP | 3.52 ± 0.46 | 0.80 ± 0.45* | 49.48 ± 6.65 | 0.60 ± 0.55* | 71.24 ± 6.78† |
| Non-OP | 3.64 ± 0.69 | 1.20 ± 0.45* | 38.20 ± 5.37 | 0.80 ± 0.45* | 66.38 ± 5.23 | |
| Placebo | OP | 3.68 ± 0.57 | 2.51 ± 0.45# | 31.67 ± 4.59 | 0.60 ± 0.55# | 51.48 ± 2.94 |
| Non-OP | 3.57 ± 0.52 | 1.60 ± 0.55 | 21.28 ± 5.64 | 1.80 ± 0.71 | 25.12 ± 4.61 |
* Statistically significant (p < 0.001) within the group.
# Statistically significant (p < 0.05) within the group.
† Statistically significant relative to NOP-placebo (p < 0.001).